treatment of patients with Metastatic Epidermal growth factor receptor (EGFR) T790m mutation-positive Osimertinib 80 mg once a
positive Osimertinib 80 mg once a
Tablets
Trade Information
Cash in Advance (CID)
20 Box Per Week
2 Week
1*30/BOX
Australia South America Eastern Europe Western Europe Middle East Central America Asia North America Africa
All India
Product Description
Tagrix 80 Mg Tablets Product Description: Product Details:Category: Lung Cancer Type Allopathic Dosage Form : OralDose: 1 tab once in a day Packaging Size 10''s x 3 Product Description:We are an acclaimed name engaged in providing our precious clients a superior quality range of Tagrix Tablets. Features:Accurate formulation No side effects Highly effective Description: Each film coated tablet contains OSIMERTINIB mesylate INN equivalent to Osimertinib 40mg and 80mgOsimertinib is a Kinase Inhibitor Indicated for the treatment of patients with Metastatic Epidermal growth factor receptor (EGFR) T790m mutation-positive Osimertinib 80 mg once a day tablet Number of tablets: 30Strength : 80 mg